Form 4/A for DCOY Decoy Therapeutics Inc.
Accepted 2022-06-06 00:00:00 ET · period of report 2020-08-21 · accession 0001615219-22-000093 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AI | 2022-06-06 | 2020-08-21 | DCOY | HANISH ARNOLD C | Dir | P - Purchase | $0.98 | +4,000 | 11.3K | +54% | +$3,920 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2020-08-21 | P | A | 4,000 | $0.98 | 11,350 | I By Arnold C. Hanish Trust | — | — | (F1) This Form 4/A is being filed to amend the Form 4 filed by the Reporting Person on August 24, 2020 to reflect that the securities reported are indirectly beneficially owned as indicated herein. |